•
Jun 30, 2024

PTC Therapeutics Q3 2024 Earnings Report

Total Revenue
$197M
Previous year: $197M
+0.1%
EPS
-$1.39
Previous year: -$1.76
-21.0%
Gross Profit
$171M
Previous year: $187M
-8.5%
Cash and Equivalents
$1.09B
Previous year: $295M
+270.8%
Free Cash Flow
-$77.5M
Previous year: -$20.9M
+271.3%
Total Assets
$1.92B
Previous year: $1.26B
+52.1%

PTC Therapeutics

PTC Therapeutics